Rakovina Therapeutics Inc. (TSXV: RKV)
Health Care · Biotechnology · CA
CA$0.20
+2.63% today · -62.0% 1Y
Rakovina Therapeutics Inc. (TSXV: RKV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.37M.
Over the last twelve months the share price has lost 62.0%, trading between 0.09 and 0.53.
Tweenvest scores Rakovina Therapeutics Inc. across four factors: quality 7/100. Its strongest factor is quality.
RKV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.37M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.41
- Dividend yield
- —
- Beta (5Y)
- -0.22
- 52-week high
- CA$0.53
- 52-week low
- CA$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 24.41M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $263.50 | -0.55% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.25 | +0.21% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $145.32 | -0.55% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.33 | +0.05% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $825.06 | -1.08% |
| argenx SEENXTBR: ARGX | $65.85B | €867.40 | -3.84% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $135.44 | -6.64% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.